Role of myeloid cells in mediating the effects of lipids on ulcerative colitis

TL;DR

This study shows that certain lipids can cause ulcerative colitis, with myeloid cells acting as mediators, offering new treatment possibilities.

Contribution

Identifies myeloid cells as key mediators of lipid effects on ulcerative colitis through causal and mediation analyses.

Findings

Six lipid types were found to have a causal relationship with ulcerative colitis.

Four immune cell phenotypes, including CD11b on CD33+ HLA DR+ CD14dim, mediated the lipid-UC association.

Phosphatidylcholine (PC) (16:0_0:0) acted as an exposure factor with a 15.38% mediation effect via myeloid cells.

Abstract

To evaluate the causal relationship between lipids and ulcerative colitis (UC) through Mendelian Randomization (MR), and to further investigate the involvement of immune cells in mediating this process.

Utilizing summary statistics from genome-wide association studies (GWAS) of individuals with European ancestry, we analyzed the causal link between 179 lipid types and UC (2,569 UC cases and 453,779 controls) through Two-sample Mendelian randomization (2SMR) and Bayesian-weighted MR (BWMR). Based on this, a mediation screening of 731 immune cell phenotypes was conducted to identify exposure and mediator factors. Lastly, the role and proportion of immune cells in mediating the causal effects of lipids on UC were assessed via reverse MR (RMR) and two-step MR.

The results of MR showed that there was a causal relationship between the six genetically predicted lipid types and UC (P <0.05), and the four immune cell phenotypes were identified as mediators of the association between lipids and UC. Notably, Phosphatidylcholine (PC) (16:0_0:0) served as the exposure factor, and myeloid cells CD11b on CD33+ HLA DR+ CD14dim acted as the mediator. Mediation analysis showed that CD11b on CD33+ HLA DR+ CD14dim had a mediation effect of -0.0205 between PC (16:0_0:0) and UC, with the mediation effect ratio at 15.38%.

Our findings elucidate the causal effect of lipids on UC and identify the significant mediating role of myeloid cells CD11b on CD33+ HLA DR+ CD14dim in regulating UC through PC (16:0_0:0), offering new pathways and strategies for UC clinical treatment.

Figures